Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Interleukin-2 4 Nivolumab 3 Melphalan 3 pembrolizumab 2 tremelimumab 1 tislelizumab 1 fludarabine 1 encorafenib 1 binimetinib 1 apatinib 1 Tramadol 1 Technetium 1 Surgical Procedures, Operative 1 Metastasectomy 1 Ipilimumab 1 Immunotherapy 1 Ibuprofen 1 Fecal Microbiota Transplantation 1 FMT protocol 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Melanoma × Technetium × Clear all

NCT07552597 2026-04-27

MagMen-II

Vastra Gotaland Region

Phase 3 Not yet recruiting

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡